arlevert tablets
hennig arzneimittel gmbh & co. kg - cinnarizine; dimenhydrinate - oral tablet - 20mg ; 40mg
elmiron
bene-arzneimittel gmbh - pentosan polysulfate sodium - cystitis, interstitial - urologicals - elmiron is indicated for the treatment of bladder pain syndrome characterized by either glomerulations or hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition.,
para-denk 500 tablets
bene-arzneimittel gmbh herterichstrasse 1-3 - paracetamol - tablets - 500mg
laif 600
bayer israel ltd - hypericum perforatum - film coated tablets - hypericum perforatum 612 mg - symptoms of mild to moderate depression. treatment is recommended for up to 24 weeks.
selesyn 100 micrograms/2 ml, oral solution (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - oral solution - 100 µg/2ml - selenium; sodium selenite
selesyn 500 micrograms/10 ml, oral solution (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - oral solution - 500 microgram(s) - selenium; sodium selenite
vesanoid 10 mg soft capsules
cheplapharm arzneimittel gmbh - tretinoin - capsule, soft - 10 milligram(s) - cytostatic-differentiating agent
xenical
cheplapharm arzneimittel gmbh - orlistat - obesity - antiobesity preparations, excl. diet products - xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (bmi) greater or equal to 30 kg/m2, or overweight patients (bmi > 28 kg/m2) with associated risk factors.treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy.
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 6,25mg
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 12,5mg